Connect with us

Business

Pakistan Seeks to Unlock Trillions in Mineral Wealth at PMIF26 – SUCH TV

Published

on

Pakistan Seeks to Unlock Trillions in Mineral Wealth at PMIF26 – SUCH TV



Pakistan is taking decisive steps to transform its vast but underutilized mineral resources into a driver of strategic economic growth, as the country prepares to host the Second Pakistan Minerals Investment Forum (PMIF26) on April 8–9 in Islamabad.

With an estimated trillions of dollars in untapped reserves—including copper, gold, lithium, cobalt, rare earth elements, and gemstones—Pakistan aims to position itself as an investment-ready and responsible player in the global minerals market.

Despite its rich resource base, mineral exports remain minimal, and local communities have historically seen limited economic benefits.

The upcoming PMIF26 seeks to change this trajectory by promoting transparency, policy reform, and international partnerships.

The forum follows the success of PMIF25, which attracted over 5,000 delegates from 50 countries and resulted in 14 memorandums of understanding (MOUs).

Pakistan’s mineral wealth is largely concentrated in Balochistan, Khyber Pakhtunkhwa, and Gilgit-Baltistan, regions long underexplored due to security and infrastructure challenges.

Among the flagship projects is Reko Diq, one of the world’s largest undeveloped copper-gold deposits, estimated to contain over 5.9 billion tonnes of ore.

In addition, Pakistan’s gemstone reserves—valued at approximately $450 billion—remain vastly underexploited, with annual exports standing at just $5.8 million.

To address this gap, the government has introduced the country’s first national gemstone policy framework, targeting $1 billion in exports within five years through certification reforms, value addition, and youth-led entrepreneurship.

Prime Minister Shehbaz Sharif has approved the establishment of international-standard laboratories, certification systems, and centers of excellence to modernize the sector and attract private investment.

The reforms aim to integrate local miners and communities into formal supply chains while improving productivity and export potential.

Federal Minister for Petroleum Ali Pervaiz Malik has emphasized that PMIF26 will serve as a global platform for promoting sustainable mining, attracting foreign investment, and enhancing policy clarity.

The forum will feature strategic conferences, technical sessions, an international gemstone exhibition, and a comprehensive resource library for investors.

Pakistan is also strengthening international collaboration. A recent MOU between US-based Strategic Metals (USSM) and Pakistan’s Frontier Works Organization (FWO) highlights growing cooperation in critical minerals production and technology transfer.

US officials have described such partnerships as vital to both economic and strategic security.

Experts estimate that comprehensive development of Pakistan’s mineral and gemstone sector could add $5–7 billion annually to GDP over the next decade and create tens of thousands of jobs.

The government has stressed that environmental protection, worker safety, ESG compliance, and domestic value addition will remain central to future mining projects.

By processing minerals locally rather than exporting raw materials, Pakistan aims to maximize economic returns and ensure inclusive growth.

As global demand for critical minerals accelerates, PMIF26 is being positioned as a strategic milestone—signaling Pakistan’s transition from untapped potential to measurable economic performance and sustainable development.



Source link

Business

Anthropic officially designated a supply chain risk by Pentagon

Published

on

Anthropic officially designated a supply chain risk by Pentagon



The supply chain risk designation of the artificial intelligence firm is a first for a US company.



Source link

Continue Reading

Business

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Published

on

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease


Thomas Fuller | SOPA Images | Lightrocket | Getty Images

UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.

The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.

“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”

The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.

UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.

The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”

UniQure didn’t immediately comment.

The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.



Source link

Continue Reading

Business

US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India

Published

on

US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India


The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.



Source link

Continue Reading

Trending